Further, immunohistochemical results demonstrated that DMC-BH treatment decreased expression of the glioma related proliferation marker Ki67 in GSCs xenografts (Figure 6C), and increased the number of TUNEL positive cells (Figure 6D). Here, MKI67 is linked to central nervous system cancer.